U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Source: Check out ABC 7 for more…
FDA restricts Johnson & Johnson's COVID-19 vaccine due to rare but serious risk of blood clots
Published in New York City
More from New York CityMore posts in New York City »
Be First to Comment